Inhibition of Thyroid Hormone Signaling in the Zona Incerta Alters Basal Metabolic Rate, Behavior and Serum Glucocorticoids in Male Mice.


Journal

Thyroid : official journal of the American Thyroid Association
ISSN: 1557-9077
Titre abrégé: Thyroid
Pays: United States
ID NLM: 9104317

Informations de publication

Date de publication:
27 Aug 2024
Historique:
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 27 8 2024
Statut: aheadofprint

Résumé

It has long been known that thyroid disease can lead to changes in energy metabolism, thermoregulation, and anxiety behavior. While these actions have been partially attributed to thyroid hormone receptor α1 (TRα1) action in brain, the precise neuroanatomical substrates have remained elusive. We used PET-CT scans to identify brain regions affected by thyroid hormone. Then we inhibited TRα1 signaling specifically in the most affected region, the zona incerta, a still mysterious region previously implicated in thermogenesis and anxiety. To this end we used an adeno-associated virus (AAV) expressing a dominant-negative TRα1R384C in wild-type mice and phenotyped the animals. Finally, we used tyrosine hydroxylase-Cre mice to test specifically the contribution of zona incerta dopaminergic neurons. Our data showed that AAV-mediated inhibition of TRα1 signaling in the zona incerta lead to increased energy expenditure at thermoneutrality, while body temperature regulation remained unaffected. Moreover, circulating glucocorticoid levels were increased, and mild habituation problem was observed in the open field test. No effects were observed when TRα1 signaling was selectively inhibited in dopaminergic neurons. Our findings suggest that altered thyroid hormone signaling in the zona incerta is not involved in body temperature regulation, but can affect basal metabolism and modulates stress responses.

Sections du résumé

BACKGROUND BACKGROUND
It has long been known that thyroid disease can lead to changes in energy metabolism, thermoregulation, and anxiety behavior. While these actions have been partially attributed to thyroid hormone receptor α1 (TRα1) action in brain, the precise neuroanatomical substrates have remained elusive.
METHODS METHODS
We used PET-CT scans to identify brain regions affected by thyroid hormone. Then we inhibited TRα1 signaling specifically in the most affected region, the zona incerta, a still mysterious region previously implicated in thermogenesis and anxiety. To this end we used an adeno-associated virus (AAV) expressing a dominant-negative TRα1R384C in wild-type mice and phenotyped the animals. Finally, we used tyrosine hydroxylase-Cre mice to test specifically the contribution of zona incerta dopaminergic neurons.
RESULTS RESULTS
Our data showed that AAV-mediated inhibition of TRα1 signaling in the zona incerta lead to increased energy expenditure at thermoneutrality, while body temperature regulation remained unaffected. Moreover, circulating glucocorticoid levels were increased, and mild habituation problem was observed in the open field test. No effects were observed when TRα1 signaling was selectively inhibited in dopaminergic neurons.
CONCLUSIONS CONCLUSIONS
Our findings suggest that altered thyroid hormone signaling in the zona incerta is not involved in body temperature regulation, but can affect basal metabolism and modulates stress responses.

Identifiants

pubmed: 39189416
doi: 10.1089/thy.2024.0209
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Julia Maier (J)

University of Lübeck, Institue of Endocrinology and Diabetes, Lubeck, Germany; Julia.Maier@uksh.de.

Riccardo Dore (R)

University of Lübeck, Institue of Endocrinology and Diabetes, Ratzeburger Allee 160, Lubeck, Germany, 23562; riccardo.dore@uksh.de.

Rebecca Oelkrug (R)

Universitätsklinikum Schleswig-Holstein, CBBM Molecular Endocrinology, Lübeck, Germany; Rebecca.Oelkrug@uksh.de.

Annika Glatzel (A)

Max Planck Institute Cologne, Cologne, Germany; annika.glatzel@sf.mpg.de.

Anna-Lena Cremer (AL)

Max Planck Institute Cologne, Cologne, Germany; anna.cremer@web.de.

Sonja Binder (S)

University of Lübeck, Institut for Experimental and Clinical Pharmacology and Toxicology, Lübeck, Schleswig-Holstein, Germany; sonja.binder@uni-luebeck.de.

Markus Schwaninger (M)

University of Lübeck, Institut for Experimental and Clinical Pharmacology and Toxicology, Lübeck, Schleswig-Holstein, Germany; markus.schwaninger@uni-luebeck.de.

Henrik Oster (H)

University of Lübeck, Institute of Neurobiology, Lubeck, Germany; Henrik.Oster@uni-luebeck.de.

Heiko Backes (H)

Max Planck Institute Cologne, Cologne, Germany; backes@sf.mpg.de.

Jens Mittag (J)

Universitätsklinikum Schleswig-Holstein, CBBM Molecular Endocrinology, Ratzeburger Allee 160, Lübeck, Germany, 23562.
United States; jens.mittag@uni-luebeck.de.

Classifications MeSH